Metagenomi, Inc. Common Stock Financial Flexibility Index
Metagenomi, Inc. Common Stock financial flexibility index. Metagenomi, Inc. Common Stock (MGX) has a Financial Flexibility Index of -0.32x as of June 2026. Free cash flow of $-19.39 Million (operating CF $-19.51 Million minus capex $125.00K) represents 0% of total liabilities ($61.13 Million). See MGX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Metagenomi, Inc. Common Stock (2021–2025)
Financial flexibility index of Metagenomi, Inc. Common Stock from 2021 to 2025. Historical Financial Flexibility Index trend for Metagenomi, Inc. Common Stock across 5 annual periods. Explore Metagenomi, Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Metagenomi, Inc. Common Stock Financial Flexibility Index by Year (2021–2025)
Metagenomi, Inc. Common Stock financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for Metagenomi, Inc. Common Stock. For the full cash flow conversion analysis, see how efficiently does Metagenomi, Inc. Common Stock generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.41x | $-88.32 Million | $-88.89 Million | $62.51 Million | ▼ -19.7% |
| 2024 | -1.18x | $-105.96 Million | $-109.07 Million | $89.74 Million | ▼ -624.1% |
| 2023 | -0.16x | $-81.59 Million | $-91.41 Million | $500.43 Million | ▼ -282.4% |
| 2022 | 0.09x | $43.70 Million | $29.72 Million | $488.91 Million | ▼ -42.6% |
| 2021 | 0.16x | $27.16 Million | $24.26 Million | $174.54 Million | — |